Orion Pharma

Orion Oyj

Type	Julkinen osakeyhtiö
Traded as	Nasdaq Helsinki: ORNBV
Industry	Pharmaceutical industry
Founded	1917
Headquarters	Espoo, Finland
Key people	Timo Lappalainen (President and CEO), Hannu Syrjänen (Chairman)
Products	Pharmaceuticals, active pharmaceutical ingredients and diagnostic tests
Revenue	€1.016 billion (2015)
Operating income	€267 million (2015)
Profit	€208 million (2015)
Total assets	€1.047 billion (2015)
Total equity	€595 million (2015)
Number of employees	3,401 (2015)
Website	www.orion.fi

Orion Corporation, founded in 1917 and headquartered at Espoo, Finland, is a Finnish company, which develops, manufactures and markets pharmaceuticals, active pharmaceutical ingredients and diagnostic tests for global markets. The company also has a large R&D unit in Turku.

Orion's are listed on the .